Education
About Us
Working with TipRanks
Follow Us
Nanobiotix SA (GB:0QAV)
:0QAV
Total Valuation
Nanobiotix has a market cap or net worth of €139.47M. The enterprise value is ―.
Market Cap€139.47M
Enterprise Value―
Share Statistics
Nanobiotix has 47,133,327 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,133,327
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nanobiotix’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee278.31K
Profits Per Employee-367.59K
Employee Count108
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Nanobiotix is ―. Nanobiotix’s PEG ratio is ―.
PE Ratio―
PS Ratio46.47
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Nanobiotix had revenue of 30.06M and earned -39.70M in profits. Earnings per share was -1.08.
Revenue30.06M
Gross Profit36.21M
Operating Income-26.78M
Pretax Income-39.58M
Net Income-39.70M
EBITDA-30.09M
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -1.04M and capital expenditures -494.00K, giving a free cash flow of -1.53M billion.
Operating Cash Flow-1.04M
Free Cash Flow-1.53M
Free Cash Flow per Share-0.03
Dividends & Yields
Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.41
52-Week Price Change-47.26%
50-Day Moving Average3.30
200-Day Moving Average3.82
Relative Strength Index (RSI)41.64
Average Volume (3m)867.00
Important Dates
Nanobiotix upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateApr 2, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Nanobiotix as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Nanobiotix has paid 120.00K in taxes.
Income Tax120.00K
Effective Tax Rate―
Enterprise Valuation
Nanobiotix EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Nanobiotix has €66.33M in cash and marketable securities with €20.52M in debt, giving a net cash position of -€17.17M billion.
Cash & Marketable Securities€66.33M
Total Debt€20.52M
Net Cash-€17.17M
Net Cash Per Share-€0.36
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Nanobiotix is €13.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€13.00
Price Target Upside336.24% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―